Ning Wu
United BioSource Corporation,
430 Bedford Street, Suite 300, Lexington, MA 02420
Tanzania
Research Article
Cost Savings Associated with the Use of Electrical Bone Growth Stimulation to Treat Diabetic Patients in the U.S. with Fracture Nonunion
Author(s): Ning Wu, Yuan-chi Lee, Daniel Segina, Nicole Benjamin, Luke Boulanger, Hallie Murray and Teresa WilcoxNing Wu, Yuan-chi Lee, Daniel Segina, Nicole Benjamin, Luke Boulanger, Hallie Murray and Teresa Wilcox
Objectives: Diabetic patients can suffer from poor bone quality and impaired vascularity often leading to increased fracture risk, delayed healing and potential fracture nonunion. Therefore, this study assessed healthcare resource utilization by diabetic patients receiving electrical bone growth stimulation (EBGS) versus Low-intensity Pulsed Ultrasound Stimulation (LIPUS) or neither (No-stim) for the management of their fracture nonunions.
Methods: Diabetic and non-diabetic patients newly diagnosed with a fracture nonunion were identified using medical and pharmacy claims and stratified by the first treatment received after nonunion diagnosis: EBGS, LIPUS, or No-stim. Patient demographics, comorbidities, fracture characteristics, and healthcare costs were analyzed before and after nonunion diagnosis. Multivariate regression analysis was used to compare healthcare costs incurre.. View More»
